Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2003, p. 8505-8518, Vol. 23, No. 23
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.23.8505-8518.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Departments of Pediatrics and Genetics, Stanford University School of Medicine, Stanford, California
Received 8 May 2003/ Returned for modification 15 July 2003/ Accepted 14 August 2003
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Each end of SB contains an inverted repeat (IR)-direct repeat (DR) structure consisting of two short DRs within an
230-bp imperfect terminal IR. These DRs (
30 bp) serve as core binding sites for the element-encoded transposase (23), and the presence of both sites within an individual IR is required for efficient transposition (24). In addition to the DRs, the left IR of SB contains a half binding site, termed HDR, which acts as a transpositional enhancer-like sequence (25). Specific binding to the DRs is mediated by an N-terminal, paired-domain-like DNA-binding domain of the transposase (23, 25). The C-terminal, catalytic domain of the transposase is responsible for all DNA cleavage and strand transfer reactions and is characterized by the presence of a conserved amino acid triad, the DDE motif. This catalytic triad is found in a large group of recombinases, including many eukaryotic and bacterial transposases, retroviral integrases, and the RAG1 V(D)J recombinase, involved in immunoglobulin gene rearrangements (50).
Like V(D)J recombination, the mobilization of SB elements is a specialized form of DNA recombination and occurs by a cut-and-paste pathway involving a DNA intermediate. This transposition process involves five distinct stages, the first four of which include (i) association of the transposase with its binding sites within the transposon IRs, (ii) assembly of an active synaptic complex in which the two ends of the element are paired and held together by bound transposase subunits, (iii) transposase-mediated excision of the element from its original donor site, and (iv) reinsertion of the excised element into a new target site (TA dinucleotide). This joining step occurs when the 3' hydroxyl (3' OH) at each end of the excised element performs a nucleophilic attack on the host DNA, producing an integration intermediate that contains single-strand gaps in the flanking host DNA sequence. In the final stage of the transposition process, the noncomplementary ends of the broken donor DNA molecule are processed and rejoined and the gaps are filled at the insertion site. These repair processes generate a small excision site footprint, consisting of a few base pairs of transposon end sequence, as well as a characteristic duplication of the target TA dinucleotide at the insertion site (Fig. 1). Although it is generally assumed that host repair enzymes remove the DNA damage produced during SB element transposition in mammalian cells, the identity of the specific host factor(s) involved in these important processes has not been clearly defined.
|
Genetic and biochemical studies of mammalian cells have identified several factors involved in the NHEJ pathway. These include the DNA-dependent protein kinase catalytic subunit (DNA-PKcs), the Ku70/Ku80 heterodimer, Artemis, and the DNA ligase IV/XRCC4 complex (28). In response to a DSB, Ku heterodimers bind to and facilitate the initial alignment of the two DNA termini and then stimulate the recruitment of DNA-PKcs, thus forming an active DNA-PK complex (20). DNA-PKcs also forms a physical complex with Artemis, which alone possesses 5'-to-3' exonuclease activity (39). Upon complex formation, DNA-PKcs phosphorylates Artemis, which consequently acquires endonucleolytic activity on 5' and 3' overhangs, as well as hairpins, including those generated by the RAG complex during V(D)J recombination (39). Finally, biochemical fractionation studies suggest that the Mre11/Rad50/NBS1 (MRN) complex, which exhibits both nuclease and DNA end-bridging activity in vitro, may play a key role in aligning DNA ends in a synaptic complex immediately prior to ligation by the DNA ligase IV/XRCC4 complex (8, 22).
In this report, we investigated what role, if any, NHEJ plays in the response to DNA transposition in mammalian cells. We triggered SB element mobilization from extrachromosomal plasmids in Ku- or DNA-PKcs-deficient and wild-type control cells by expressing the SB transposase in trans from a transfected plasmid. We then studied the requirement for DNA-PK in gap repair during transposon integration and in the rejoining of DSBs produced at excision sites. Herein we show efficient transposon integration in the soma of DNA-PK-deficient scid mice and in rodent cells lacking either Ku or DNA-PKcs, suggesting that DNA-PK activity is not essential for proper DNA repair after transposon insertion. We report that, instead, DNA-PK activity, especially its regulatory component (Ku), is necessary for proper rejoining of the double-stranded DNA gaps left after SB element excision in mammals. DNA transposition in the absence of Ku was highly error prone, resulting in significant degradative loss of the individual DNA termini and frequent recombination with ectopic templates. Interestingly, similar types of misrepair events were also observed after inducing chromosomal transposition in a wild-type human cell line, suggesting that transposase activity might facilitate recombination activity in vertebrates. These studies reveal additional parallels between SB element excision and V(D)J recombination and suggest a potential role for transposition-induced recombination in the evolution of vertebrate genomes.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Plasmid construction. Plasmids pCMV-SB, pCMV-mSB, pCMV-GFP, pTnori, phAAT, and pThAAT have all been previously described (66). For the purposes of our methylation-sensitive Southern blot analyses, we isolated pThAAT from both DH10B (dam-positive) and GM48 (dam-negative) bacterial host strains. The plasmid pTpuro containing a PGK-driven puromycin-marked transposon was made by inserting a 1.7-kb SalI fragment from pPGK-Puro (kindly provided by P. Laird, Whitehead Institute) into XhoI-treated pT-MCS (66). To produce the lentivirus-based reporter construct pLNTH-15, we first produced an SB transposon containing a hygromycin expression cassette by inserting a 2-kb BsmI fragment from pTK-Hyg (Clontech) into XhoI/BsmI-treated pT-MCS by blunt end ligation.
Southern blot analysis of transposon integration in mouse liver. We purified the pThAAT vector from dam-positive bacteria and injected it (25 µg) into both C57BL/6 and C57BL/6-scid mice together with 1 µg of either pCMV-SB (n = 6 mice) or pCMV-mSB (n = 3 mice). Ten months after vector administration, we performed a surgical partial (two-thirds) hepatectomy in order to facilitate demethylation of DpnI recognition sites within integrated copies of the transposon. Forty-five days later, mice were sacrificed and liver DNA was prepared by a salting out method. For Southern blot analyses, we digested 10 µg of mouse liver DNA with DpnI, HindIII (cuts twice within the transposon), or DpnI and HindIII together and then separated it by ethidium bromide agarose gel electrophoresis and transferred it to nitrocellulose. Membranes were hybridized to a radiolabeled 1.7-kb hAAT fragment and subjected to autoradiography.
Cells and cell culture. HeLa, 293-T, V79-4 (hamster lung), Ku86-deficient CHO-K1-derived (xrs-5), and V79-4-derived (XR-V15B) cell lines were all obtained from the American Type Culture Collection and were cultured in Dulbecco's modified Eagle's medium (DMEM) containing high glucose, 10% fetal bovine serum (FBS), 1x penicillin-streptomycin, and 4 mM L-glutamine. S-MHB-2 and C-MHB-2 cells were kindly provided by C. Kirchgessner (Stanford University) and are derived from transformed fibroblasts from ST.SCID mice and congenic C.B-17 parent mice, respectively (51). These cells were grown in the same medium supplemented with 500 µg of Geneticin (Gibco, BRL)/ml. CHO-K1 (hamster ovary) cells were grown in Kaighns modification of Hams F-12 medium with 10% FBS. All cell lines were maintained at 37°C in a humidified atmosphere of 5% CO2.
Assay for transposition in mammalian cells. We used a genetic assay to study transposition in the presence and absence of known cellular DNA repair factors. HeLa, CHO-K1, xrs-5, V79-4, and XR-V15B cells were all plated on six-well dishes the day before cotransfection with a plasmid containing a neomycin gene-marked transposon (pTnori) together with either pCMV-SB or pCMV-mSB as a control using Superfect (Qiagen). Transfected cells were trypsinized 2 days later, diluted into DMEM containing 600 µg of G418/ml, and growth selected for a period of 2 weeks. At this time, G418-resistant (G418R) colonies were fixed, stained, and counted to determine the relative amount of transposase-mediated integration in each cell line. To study transposition in S-MHB-2 and C-MHB-2 cells, which already contain a neo cassette from previous studies (51), we substituted a plasmid containing a puromycin gene-marked transposon (pTpuro) for pTnori and performed growth selection in DMEM containing 5 µg of puromycin/ml. In every case, transfections were done in triplicate and produced similar results.
Establishment of chromosomal transposition reporter cell lines.
We studied the repair of transposase-induced DSB in host cell chromosomes using a lentivirus-based reporter system to detect rare excisions from various chromosomal loci. To do this, we first produced a replication-defective human immunodeficiency virus type 1 (HIV-1)-based vector (LNTH) containing a transposition-dependent reporter construct by a triple-transfection procedure (44). Briefly, we transfected a 10-cm-diameter dish of 293-T cells by the calcium phosphate method with 3.5 µg of pMD.G, 6.5 µg of pCMV
8.74, and 10 µg of pLNTH-15 in the presence of 27.5 µM chloroquine. The medium was changed 8 h later, and virus-containing medium was harvested 40 h posttransfection. Virus was titered by an ELISA method (Alliance; Dupont-NEN) that determines the HIV p24 Gag antigen concentration.
We infected HeLa and Ku86-deficient XR-V15B cells with the LNTH reporter virus at a low multiplicity of infection (0.1). Two days later, we trypsinized these cells and diluted them into DMEM containing 300 µg of hygromycin B (Gibco, BRL)/ml for growth selection for at least 2 weeks. Individual hygromycin-resistant (HygR) colonies were picked, amplified, and screened for complete sensitivity to G418 drug selection in the absence of transposase expression. Genomic DNA was prepared from each HygR G418S clone by a salting out procedure and subjected to Southern blot analyses following treatment with either BglI (cuts once) or AvaI (cuts twice) to identify clones containing a single full-length copy of the testing construct at different chromosomal loci. Four HeLa-derived and eight XR-V15B-derived clones were expanded for further analysis.
To trigger excision of the SB element from these chromosomal sites, we transfected
107 cells from each reporter line with 20 µg of pCMV-SB or pCMV-GFP as a control using Superfect (Qiagen). Transfection efficiencies for both cell types were analyzed the next day by fluorescence microscopy and found to be
15%. Three days after transfection, transposase- and green fluorescent protein (GFP)-expressing cells were growth selected for 3 weeks in DMEM containing 600 µg of G418/ml. Each G418-resistant colony (produced only from HeLa-derived pCMV-SB-transfected cultures) was picked and expanded for further analysis.
PCR, Southern blotting, and expression-based analyses of transposon reinsertion. To characterize the frequency of transposon reinsertion following SB-mediated transposon excision, we analyzed the genome of each G418R clone by PCR for the presence of the transposon using oligonucleotide primers Hyg-1A (5'-GAGGCCATGGATGCGATCGCTGCG) and Hyg-1B (5'-ATTGCGTCGCATCGACCCTGCGCC). The proportion of G418R clones that supported growth in DMEM containing 300 µg of hygromycin/ml was determined to estimate the frequency of transposon silencing following transposon reinsertion into random chromosomal sites. The diversity of reinsertion sites was analyzed by genomic Southern blot analysis of G418R clones using SpeI (cuts once) and a radiolabeled probe specific for the transposon.
PCR and sequence analysis of DSB repair products following SB element excision. We studied the repair of DNA DSBs following transposon excision from extrachromosomal plasmid DNA in both cultured mammalian cells and in the somatic tissue of adult mice. To do this, we cotransfected Ku86-expressing (V79-4 and CHO-K1) and Ku86-deficient (XR-V15B and xrs-5) cell lines with pTnori and either pCMV-SB or pCMV-mSB as a control and then performed a standard Hirt DNA extraction 30 h later. To study in vivo DSB repair in the presence and absence of DNA-PK activity, we also injected C57BL/6 and C57BL/6-scid mice via the tail vein with 25 µg of pThAAT or a control vector (phAAT) together with 1 µg of either pCMV-SB or pCMV-mSB and then isolated total liver DNA either 2 days or 30 days later by salting out. In each of these studies, we used 500 ng of DNA together with oligonucleotide primers puc1 (5'-TACGCCAGCTGGCGAAAG) and puc2 (5'-AGCTCACTCATTAGGCAC) to amplify excision repair products. PCR products were analyzed by ethidium bromide gel electrophoresis, excised, and cloned into the pCR4-TOPO vector (Invitrogen) for DNA sequence analysis. To characterize the repair pathways involved in rejoining transposase-induced DSBs in host cell chromosomes, we amplified a DNA segment encompassing the transposon donor site from the genome of HeLa-derived G418-resistant LNTH clones using oligonucleotide primers HIV-1A (5'-CAGCTCCAGGCAAGAATCCTG) and NEO-1 (5'-GCCCAGTCAAGCCGAATAGCC). Each PCR product was analyzed by ethidium bromide gel electrophoresis, gel purified, and subjected to direct DNA sequencing.
| RESULTS |
|---|
|
|
|---|
1-antitrypsin expression cassette (pThAAT) flanked by the IR-DR structure (Fig. 2A) together with a transposase plasmid encoding either the wild-type SB transposase (pCMV-SB) or a catalytically inactive mutant transposase (pCMV-mSB) as a control. Compared with pCMV-mSB-injected control mice, both normal (data not shown) and DNA-PK-deficient scid mice (Fig. 2B) expressed
65-fold more serum hAAT for a period of 10 months. Importantly, expression in scid mice treated with active transposase remained essentially unchanged during a 4-week time period following a partial (two-thirds) surgical hepatectomy, which is consistent with stable chromosomal integration irrespective of DNA-PK activity. To confirm these findings at the molecular level, we performed Southern blot analyses using the restriction endonuclease DpnI to differentiate between episomal and integrated forms of transposon DNA in these mice. Since this enzyme recognizes the methylated sequence GmATC, which is present eight times within the transposon portion of the pThAAT vector (Fig. 2A), extrachromosomal forms of the vector are completely digested, whereas integrated transposon copies that have undergone sufficient replication to completely demethylate these DpnI sites remain resistant to DpnI cleavage (Fig. 2C). Using this approach, we analyzed DNA from the livers of both normal (n = 9) and DNA-PK-deficient (n = 9) scid mice. Irrespective of the presence or absence of DNA-PK activity, mice which received active transposase contained an average of 0.25 copies of DpnI-resistant transposon DNA per diploid liver genome (Fig. 2D and data not shown). These data suggest that DNA-PK activity is not required in vivo for stable transposase-mediated insertion into host cell chromosomes.
|
|
Deficiency of DNA-PK activity facilitates transposon integration in cultured mammalian cells.
We used a genetic approach to investigate the requirement for DNA-PK activity in SB element transposition in cultured mammalian cells. To do this, we cotransfected normal and DNA repair-deficient mammalian cell lines with a plasmid containing a neomycin gene-marked transposon (pTnori) together with a helper plasmid encoding either active transposase (pCMV-SB) or catalytically inactive transposase (pCMV-mSB) as a control. We then quantified the number of stable integration events in each cell line following a 2-week growth selection in the antibiotic G418. Although cells deficient in either DNA-PKcs or Ku86 produced approximately 25% less total G418-resistant colonies than their normal parental controls, the ratio of transposase-mediated integration events to illegitimate recombination events was found to be
1.6-fold higher in all DNA-PK-deficient cells than in their respective wild-type controls (Table 1). These results further demonstrate that DNA-PK-dependent NHEJ activity is not essential for stable transposition into mammalian cell chromosomes.
|
Mammalian Ku protein is required for accurate DSB repair after SB element transposition. To determine whether NHEJ factors are involved in repairing the DSBs produced during transposon excision in mammalian cells, we studied the excision step of SB element transposition by PCR using Hirt DNA obtained from normal and Ku-deficient hamster cells following transfection with transposon-containing and transposase-encoding plasmids. In contrast to pCMV-mSB-transfected control cells, both normal and Ku-deficient cells were capable of supporting the production of an appropriately sized PCR product following expression of the wild-type transposase, although the amount of specific end-joining activity observed was significantly reduced in the absence of Ku compared to that for each of the controls (Fig. 4A). These results are consistent with transposase-mediated SB element excision and demonstrate that mammalian cells possess a Ku-independent end-joining activity that can process transposase-induced DSBs.
|
A reporter system for studying DSB repair following transposon excision from host cell chromosomes. We considered the possibility that the analysis of DNA repair using naked DNA might not adequately reflect repair of cellular DNA, which is known to rapidly associate with nuclear histone proteins to form chromatin. We therefore studied DNA repair following SB element excision from mammalian cell chromosomes using a positive-selection scheme that permits detection and analysis of rare chromosomal transposition events at random single-copy genetic loci (Fig. 5A). This strategy made use of a selectable excision reporter construct in which a hygromycin-marked SB transposon was inserted into a selectable neomycin marker cassette to inactivate its function. This entire reporter construct was incorporated into a lentivirus to facilitate its delivery to random genomic loci of host cells. Following stable transduction with this lentivirus-based vector and expression of the transposase in trans, movement of the nonautonomous SB element is triggered, resulting in reactivation of the neomycin resistance cassette. Therefore, this selection-based approach permits the rapid isolation of cells that have undergone genomic transposon excision and DSB repair.
|
Whereas none of the reporter lines reverted to G418 resistance in the presence of GFP, we obtained a total of 28 G418R clones after transposase expression in the four HeLa-based reporter lines. This corresponded to an average of 5 x 10-6 transposition events per transfected HeLa cell (data not shown), which is equivalent to the frequency of chromosomal SB transposition observed previously at the Hprt locus in mouse embryonic stem cells (38). We characterized each G418R clone at the molecular level using a Southern blotting approach. Assuming high-fidelity repair following precise excision of the SB element, we could predict the postexcision structure in these G418R clones (Fig. 5A). Using a neo-specific probe, we detected the predicted 3.1-kb AvaI restriction fragment in 20 of 28 clones by Southern blot analysis (Fig. 5B), which is consistent with proper transposon excision from the neomycin resistance cassette. Interestingly, six of the remaining eight clones produced smaller AvaI fragments, ranging from 2.5 to 3.0 kb, whereas two clones exhibited a detectably larger 3.3-kb fragment. To further demonstrate that transposon loss occurred by a transposase-mediated process, we studied transposon reinsertion frequencies in G418R clones by both transposon-specific PCR (data not shown) and Southern blot analyses using the restriction enzyme SpeI, which cuts once within the HygR transposon. Results demonstrate frequent reinsertion of elements into novel genomic loci, which is consistent with transposase-mediated element excision from the donor site (Fig. 5C). These were concordant with results obtained in expression-based studies in which we assayed for expression of transposed sequences by selection in hygromycin, although we identified at least two instances where the transposon jumped into transcriptionally inactive cellular DNA (Fig. 5B, clones 6-2 and 8-1). Taken together, these results suggest that cellular DSB repair after SB element transposition in NHEJ-proficient mammalian cells is generally precise but can sometimes result in significant deletion and/or addition of DNA sequences at the excision site.
In marked contrast to the HeLa-derived clones, none of the eight Ku-deficient reporter lines produced a single G418R colony following transposase expression. This result is perhaps not surprising considering the facts that (i) the frequency of SB chromosomal transposition observed in this study and elsewhere (38) was extremely low and (ii) the frequency of rejoining genomic DSBs is more than 100-fold lower in the absence of Ku (34). Whether the high-stringency selection-based approach used here precludes the recovery of most Ku-independent repair events, which often involve significant addition and/or deletion of DNA sequences, remains presently unclear. However, considering our earlier work showing efficient SB transposition in Ku-deficient cells, we propose that Ku is likely essential for efficient and proper rejoining of genomic transposase-induced DSBs.
Transposon excision from HeLa cell chromosomes results in frequent and extensive loss of flanking cellular DNA. We amplified a fragment encompassing the excision site from each of the HeLa-derived G418R clones by PCR and sequenced it. In comparison to clones derived from various wild-type mouse cells, those isolated from wild-type human cells in which DSB repair events occurred exhibited a wider diversity of 1- to 3-bp footprints after SB element excision, as well as a much higher frequency of DNA loss in the regions surrounding the excision site. Deletions of flanking regions ranged in size from as little as 2 bp to as much as 610 bp and sometimes extended into the neighboring simian virus 40 promoter (Fig. 6A, clones 11-7 and 8-1). The isolation of these clones suggests that the upstream retroviral long terminal repeat promoter can sometimes compensate for progressive DNA degradation after SB element excision. Interestingly, we could identify 1 to 7 bp of microhomology at the junctions of clones which had undergone large deletion of flanking sequences (n = 6; Fig. 6B, top), suggesting a role for microhomology-dependent strand annealing in the repair of transposase-induced DNA lesions. Furthermore, the one clone which was found to contain a 235-bp LINE-1 (L1MB7-type) retrotransposon insertion from chromosome X (clone 6-2; positivity, 241/242; GenBank accession no. AC097259) also contained a 6-bp stretch of homologous sequence at one end, suggesting that recombination with ectopic sequences can also occur in wild-type cells (Fig. 6B, bottom). Taken together, these data suggest that significant loss and/or addition of cellular DNA can occur in human cells after SB element transposition.
|
| DISCUSSION |
|---|
|
|
|---|
|
Our work suggests that, prior to ligation by the DNA ligase IV/XRCC4 complex, the Ku/DNA-PKcs complex limits processing of the free DNA ends produced during SB element transposition in mammalian cells. Interestingly, Ku is also known to bind the termini of the P element and to protect the P element ends when transposition creates a double-strand gap in Drosophila (5, 58). Taken together, these results suggest that DNA-PK activity provides a function necessary for transpositional recombination in eukaryotes.
Although the identities of other NHEJ factors involved in DNA transposition remain poorly defined, the production of DSBs with incompatible 3'overhangs during SB element excision strongly suggests the involvement of a nuclease that can process these ends to facilitate efficient rejoining. Potential factors involved in this end-processing step could include Artemis (39) or possibly the MRN complex (60). Indeed, recent studies in our laboratory suggest that inhibiting the MRN complex can dramatically impair SB element-induced DSB repair (S. Yant, unpublished data). Alternatively, it is possible that SB transposase activity itself facilitates the processing of the broken DNA molecule. Indeed, the closely related RAG1/RAG2 recombinase and Tn10 transposase both possess 3' flap endonuclease activity (56). Whether SB is capable of performing an analogous function is uncertain. Future studies into these and other related issues will likely require the development of an in vitro transposition system for SB, which does not currently exist.
Studies of mammalian cells with the rare restriction endonuclease I-SceI have shown that, although the vast majority of end-joining reactions are relatively accurate, a small minority of DSBs in normal cells can be processed by an error-prone NHEJ pathway (15). This repair route can function independent of Ku and appears to involve the joining of DNA ends at regions of microhomology (1 to 4 bp), resulting in deletion of the intervening sequence (46). Our work described herein suggests that DNA-PK-independent pathways contribute to inaccurate repair during DNA transposition in mammals. Although most of the factors responsible for this error-prone end-joining activity remain poorly defined, a recent study has implicated BRCA1, which associates with the MRN complex, in microhomology-mediated end joining (70). In addition, in vitro studies have also identified DNA polymerase
(pol
), DNA ligase III, and exonuclease activities of 5'-3' and 3'-5' directionalities in these processes (19). Finally, a role for Mre11 and poly(ADP-ribose) polymerase-1 in DNA-PKcs-independent V(D)J recombination was recently shown (7). Future studies will thus be necessary to elucidate whether any of these alternative end-joining factors is involved in DSB repair after DNA transposition in mammalian cells.
Our studies of Ku-deficient cells suggest that mammalian cells can also remove transposase-induced DSBs by coupling conventional end joining with an error-prone homologous recombination pathway. These repair events involved insertions of ectopic DNA templates with homologous sequences and had properties consistent with aberrant end joining after aborted homologous recombination. Similarly, transposon excision in both flies (2, 17, 37, 43) and worms (47, 49) also triggers recombination with ectopic templates, resulting in the introduction of new sequences into the original donor site. Whether the events that we observed in mammalian cells involve the major RAD52 group proteins or other factors recently implicated in homologous recombination (61, 62), such as ATM (ataxia telangiectasia mutated), ATR (Rad3-related kinase), BRCA-1, BRCA-2, WRN, and BLM, is not yet known. However, since most of the insertions we recovered contained transposon DNA with at least one intact SB binding site, it is possible that the utilization of this repair pathway in nature contributed to the inactivation of these and other transposable elements (36).
Following transposase-mediated excision, the newly excised SB element must reinsert into a new target site in order to complete a full cycle of transposition. Our data suggest that cell lines deficient in DNA-PK activity support
1.6-fold more transposon insertions than parental wild-type cells. Interestingly, Baekelandt et al. also observed more-efficient lentivirus transduction in DNA-PK-deficient cells and in scid mouse brain than in infected controls, but only at low virus titers (<1 transducing unit/cell) (4). At higher virus titers, significant cytotoxicity was observed, prompting the notion that DNA-PK serves a protective role during excessive retrovirus integration (4). Importantly, irrespective of the presence or absence of DNA-PKcs, we did not observe any evidence for transposition-dependent cell death either in cell culture or in vivo in mice (S. Yant, unpublished data). These findings could suggest that the levels of SB element transposition in mammalian cells may be low enough to prevent initiation of a cell death response. Alternatively, it may be that the double-stranded ends of excised elements are actively removed by NHEJ factors via direct end-to-end joining. Although a recent report has indeed described a role for DNA-PK in the circularization of unintegrated retrovirus cDNA genomes (33), our data do not support an obvious role for NHEJ in the processing of SB elements after transposase-mediated excision. These findings could be readily explained if SB transposition involved the formation of a DNA hairpin intermediate at the transposon termini. Although hairpin formation is involved in V(D)J joining (40) and the excision of many transposable elements (6, 27, 64), this process does not appear to occur during transposition of Tc1/mariner-like elements (12). Alternatively, these results might reflect the involvement of a highly stable protein-DNA complex at the transposon termini. Such a complex could prevent reactions with cellular NHEJ factors that might otherwise diminish SB transposition efficiencies and could theoretically prevent the cell from mounting an apoptosis-inducing DNA damage response against the double-stranded ends of the excised element.
At any given time, cells deficient in DNA-PK end-joining activity are likely to contain more overall DNA damage, including DSBs, than NHEJ-proficient cells. Therefore, it is conceivable that improved transposon insertion frequencies in DNA-PK-deficient cells may originate from an inherent tendency for SB elements to insert into sites of chromosomal damage. Indeed, recent experiments utilizing the mammalian LINE-1 retrotransposon suggest that at least some transposable elements can target DSBs to facilitate repair (42). If this were true for SB elements, then such insertions into noncanonical target sites would lack flanking TA dinucleotides (Fig. 1). However, recent analysis of insertion sites from Ku86-deficient cells showed flanking TA sequences in every case examined (n = 11; S. Yant, unpublished data), suggesting that transposase-mediated insertion into endogenous DSBs may be an unlikely mechanism. Alternatively, SB elements may exhibit a targeting preference similar to that of the bacterial transposon Tn7, which preferentially transposes into regions proximal to DNA DSBs rather than the breaks themselves (45). Although we favor the latter hypothesis, additional studies will be necessary to further clarify this important issue.
As with retrovirus DNA integration, DNA transposition proceeds through a series of DNA-cutting and -joining reactions that produces an integration intermediate containing single-strand gaps in the host DNA. These gaps must be filled, and the 5' ends of the transposon must be joined to the host DNA. Although the DNA-PK complex is known to be important for joining DSBs, it is not thought to be involved in the covalent chemistry of gap repair. Therefore, a report by Daniel et al. (11) claiming an essential role for DNA-PK during retrovirus integration engendered considerable interest at the time it was published (2000). This claim was based on the observation that retrovirus transduction was reduced in murine scid cells and was accompanied by cell death due to apoptosis (10, 11). Based on the structural and functional similarities between retroviral integrases and the SB transposase (50), it seemed reasonable that DNA-PK might play an essential role in SB element integration as well. However, our analysis of SB transposition in cultured mammalian cells and in vivo in adult mice shows quite clearly that DNA-PK is not required for gap repair after transposase-mediated integration.
DNA repair pathways such as base excision repair and mismatch repair involve related gap repair steps (29). Although pol ß plays a major role in sealing the gaps during base excision repair, recent analysis of SB element transposition in pol ß-deficient cells argues against an essential role for this repair factor in transposon insertion (S. Yant, unpublished data). However, since pol
and its cofactor PCNA can also support base excision repair (29), these results likely reflect a redundancy among the components of gap repair pathways. In support of this hypothesis, in vitro studies by Yoder and Bushman have shown that several host polymerases and ligases can act together to repair the gapped DNA structure produced during retrovirus integration (67). Furthermore, although there have been conflicting reports regarding the ability of retroviral integrase to carry out gap repair through an intrinsic DNA polymerase activity (1, 67), these studies raise important questions regarding what role, if any, the SB transposase plays in the DNA damage response to SB element transposition. Finally, successful completion of the retroviral integration process was recently shown to depend on the activity of ATM and ATR (9). Future studies into these and other protein factors should help clarify the steps involved in completing transposon integration in mammalian cells.
Irrespective of which proteins are actually involved in these processes, these factors must first gain access to the gaps in integration intermediates in order for repair to take place. Following DNA cleavage at the excision site, the SB transposase is generally thought to stably associate with the transposon termini, suggesting that it may need to be actively removed from integration intermediates in mammalian cells. Studies with the MuA transposase indicate that this protein must be removed by the action of the ClpX chaperone in an ATP-dependent fashion to permit completion of Mu transposition (31, 32). Since a similar process has also been proposed for retroviral integrase (67), investigations into the requirement for active transposase disassembly during SB transposition seem warranted.
In summary, we have characterized the major DNA repair pathways involved in the damage response to transposon mobilization in mammalian cells. In the process, we have established a major role for the DNA-PK complex in removing the DNA damage produced during SB element transposition and have identified DNA transposition as an alternative new tool for studying mammalian DNA repair. Continued work in this field should help fully clarify the different molecular pathways that remove transposase-inflicted DNA damage in mammals, as well as determine how the utilization of these pathways may vary during different stages of the cell cycle and/or development. Finally, since our data suggest that SB element excision can produce a hot spot for recombination in mammalian cells, additional work may shed further light on the ongoing process of eukaryotic genome evolution and may ultimately provide insight into the origin of genetic diseases (53) and cancers associated with genetic instability.
| ACKNOWLEDGMENTS |
|---|
This work was supported by NIH grant AR44012 (M.A.K.).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Adams, M. D., M. McVey, and J. J. Sekelsky. 2003. Drosophila BLM in double-strand break repair by synthesis-dependent strand annealing. Science 299:265-267.
3. Arca, B., S. Zabalou, T. G. Loukeris, and C. Savakis. 1997. Mobilization of a Minos transposon in Drosophila melanogaster chromosomes and chromatid repair by heteroduplex formation. Genetics 145:267-279.[Abstract]
4. Baekelandt, V., A. Claeys, P. Cherepanov, E. De Clercq, B. De Strooper, B. Nuttin, and Z. Debyser. 2000. DNA-dependent protein kinase is not required for efficient lentivirus integration. J. Virol. 74:11278-11285.
5. Beall, E. L., A. Admon, and D. C. Rio. 1994. A Drosophila protein homologous to the human p70 Ku autoimmune antigen interacts with the P transposable element inverted repeats. Proc. Natl. Acad. Sci. USA 91:12681-12685.
6. Bhasin, A., I. Y. Goryshin, and W. S. Reznikoff. 1999. Hairpin formation in Tn5 transposition. J. Biol. Chem. 274:37021-37029.
7. Brown, M. L., D. Franco, A. Burkle, and Y. Chang. 2002. Role of poly(ADP-ribosyl)ation in DNA-PKcs-independent V(D)J recombination. Proc. Natl. Acad. Sci. USA 99:4532-4537.
8. Chen, L., K. Trujillo, W. Ramos, P. Sung, and A. E. Tomkinson. 2001. Promotion of Dnl4-catalyzed DNA end-joining by the Rad50/Mre11/Xrs2 and Hdf1/Hdf2 complexes. Mol. Cell 8:1105-1115.[CrossRef][Medline]
9. Daniel, R., G. Kao, K. Taganov, J. G. Greger, O. Favorova, G. Merkel, T. J. Yen, R. A. Katz, and A. M. Skalka. 2003. Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response. Proc. Natl. Acad. Sci. USA 100:4778-4783.
10. Daniel, R., R. A. Katz, G. Merkel, J. C. Hittle, T. J. Yen, and A. M. Skalka. 2001. Wortmannin potentiates integrase-mediated killing of lymphocytes and reduces the efficiency of stable transduction by retroviruses. Mol. Cell. Biol. 21:1164-1172. (Erratum, 21:2617.)
11. Daniel, R., R. A. Katz, and A. M. Skalka. 1999. A role for DNA-PK in retroviral DNA integration. Science 284:644-647.
12. Dawson, A., and D. J. Finnegan. 2003. Excision of the Drosophila mariner transposon MosI. Comparison with bacterial transposition and V(D)J recombination. Mol. Cell 11:225-235.[CrossRef][Medline]
13. Dupuy, A. J., K. Clark, C. M. Carlson, S. Fritz, A. E. Davidson, K. M. Markley, K. Finley, C. F. Fletcher, S. C. Ekker, P. B. Hackett, S. Horn, and D. A. Largaespada. 2002. Mammalian germ-line transgenesis by transposition. Proc. Natl. Acad. Sci. USA 99:4495-4499.
14. Dupuy, A. J., S. Fritz, and D. A. Largaespada. 2001. Transposition and gene disruption in the male germline of the mouse. Genes. J. Genet. Dev. 30:82-88.
15. Feldmann, E., V. Schmiemann, W. Goedecke, S. Reichenberger, and P. Pfeiffer. 2000. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining. Nucleic Acids Res. 28:2585-2596.
16. Fischer, S. E., E. Wienholds, and R. H. Plasterk. 2001. Regulated transposition of a fish transposon in the mouse germ line. Proc. Natl. Acad. Sci. USA 98:6759-6764.
17. Gloor, G. B., N. A. Nassif, D. M. Johnson-Schlitz, C. R. Preston, and W. R. Engels. 1991. Targeted gene replacement in Drosophila via P element-induced gap repair. Science 253:1110-1117.
18. Gorbunova, V., and A. A. Levy. 1997. Circularized Ac/Ds transposons: formation, structure and fate. Genetics 145:1161-1169.[Abstract]
19. Gottlich, B., S. Reichenberger, E. Feldmann, and P. Pfeiffer. 1998. Rejoining of DNA double-strand breaks in vitro by single-strand annealing. Eur. J. Biochem. 258:387-395.[Medline]
20. Hammarsten, O., and G. Chu. 1998. DNA-dependent protein kinase: DNA binding and activation in the absence of Ku. Proc. Natl. Acad. Sci. USA 95:525-530.
21. Horie, K., A. Kuroiwa, M. Ikawa, M. Okabe, G. Kondoh, Y. Matsuda, and J. Takeda. 2001. Efficient chromosomal transposition of a Tc1/mariner-like transposon Sleeping Beauty in mice. Proc. Natl. Acad. Sci. USA 98:9191-9196.
22. Huang, J., and W. S. Dynan. 2002. Reconstitution of the mammalian DNA double-strand break end-joining reaction reveals a requirement for an Mre11/Rad50/NBS1-containing fraction. Nucleic Acids Res. 30:667-674.
23. Ivics, Z., P. B. Hackett, R. H. Plasterk, and Z. Izsvak. 1997. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91:501-510.[CrossRef][Medline]
24. Izsvak, Z., Z. Ivics, and R. H. Plasterk. 2000. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J. Mol. Biol. 302:93-102.[CrossRef][Medline]
25. Izsvak, Z., D. Khare, J. Behlke, U. Heinemann, R. H. Plasterk, and Z. Ivics. 2002. Involvement of a bifunctional, paired-like DNA-binding domain and a transpositional enhancer in Sleeping Beauty transposition. J. Biol. Chem. 277:34581-34588.
26. Kay, M. A., F. Graham, F. Leland, and S. L. Woo. 1995. Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21:815-819.[CrossRef][Medline]
27. Kennedy, A. K., A. Guhathakurta, N. Kleckner, and D. B. Haniford. 1998. Tn10 transposition via a DNA hairpin intermediate. Cell 95:125-134.[CrossRef][Medline]
28. Khanna, K. K., and S. P. Jackson. 2001. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27:247-254.[CrossRef][Medline]
29. Klungland, A., and T. Lindahl. 1997. Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1). EMBO J. 16:3341-3348.[CrossRef][Medline]
30. Labhart, P. 1999. Nonhomologous DNA end joining in cell-free systems. Eur. J. Biochem. 265:849-861.[Medline]
31. Levchenko, I., L. Luo, and T. A. Baker. 1995. Disassembly of the Mu transposase tetramer by the ClpX chaperone. Genes Dev. 9:2399-2408.
32. Levchenko, I., M. Yamauchi, and T. A. Baker. 1997. ClpX and MuB interact with overlapping regions of Mu transposase: implications for control of the transposition pathway. Genes Dev. 11:1561-1572.
33. Li, L., J. M. Olvera, K. E. Yoder, R. S. Mitchell, S. L. Butler, M. Lieber, S. L. Martin, and F. D. Bushman. 2001. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J. 20:3272-3281.[CrossRef][Medline]
34. Liang, F., P. J. Romanienko, D. T. Weaver, P. A. Jeggo, and M. Jasin. 1996. Chromosomal double-strand break repair in Ku80-deficient cells. Proc. Natl. Acad. Sci. USA 93:8929-8933.
35. Liu, F., Y. Song, and D. Liu. 1999. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6:1258-1266.[CrossRef][Medline]
36. Lohe, A. R., E. N. Moriyama, D. A. Lidholm, and D. L. Hartl. 1995. Horizontal transmission, vertical inactivation, and stochastic loss of mariner-like transposable elements. Mol. Biol. Evol. 12:62-72.[Abstract]
37. Lohe, A. R., C. Timmons, I. Beerman, E. R. Lozovskaya, and D. L. Hartl. 2000. Self-inflicted wounds, template-directed gap repair and a recombination hotspot. Effects of the mariner transposase. Genetics 154:647-656.
38. Luo, G., Z. Ivics, Z. Izsvak, and A. Bradley. 1998. Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 95:10769-10773.
39. Ma, Y., U. Pannicke, K. Schwarz, and M. R. Lieber. 2002. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J. recombination. Cell 108:781-794.[CrossRef][Medline]
40. McBlane, J. F., D. C. van Gent, D. A. Ramsden, C. Romeo, C. A. Cuomo, M. Gellert, and M. A. Oettinger. 1995. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83:387-395.[CrossRef][Medline]
41. Montini, E., P. K. Held, M. Noll, N. Morcinek, M. Al-Dhalimy, M. Finegold, S. R. Yant, M. A. Kay, and M. Grompe. 2002. In vivo correction of murine tyrosinemia type I by DNA-mediated transposition. Mol. Ther. 6:759-769.[CrossRef][Medline]
42. Morrish, T. A., N. Gilbert, J. S. Myers, B. J. Vincent, T. D. Stamato, G. E. Taccioli, M. A. Batzer, and J. V. Moran. 2002. DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat. Genet. 31:159-165.[CrossRef][Medline]
43. Nassif, N., J. Penney, S. Pal, W. R. Engels, and G. B. Gloor. 1994. Efficient copying of nonhomologous sequences from ectopic sites via P-element-induced gap repair. Mol. Cell. Biol. 14:1613-1625.
44. Park, F., K. Ohashi, W. Chiu, L. Naldini, and M. A. Kay. 2000. Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24:49-52.[CrossRef][Medline]
45. Peters, J. E., and N. L. Craig. 2000. Tn7 transposes proximal to DNA double-strand breaks and into regions where chromosomal DNA replication terminates. Mol. Cell 6:573-582.[CrossRef][Medline]
46. Pfeiffer, P., W. Goedecke, and G. Obe. 2000. Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis 15:289-302.
47. Plasterk, R. H. 1991. The origin of footprints of the Tc1 transposon of Caenorhabditis elegans. EMBO J. 10:1919-1925.[Medline]
48. Plasterk, R. H. 1996. The Tc1/mariner transposon family. Curr. Top. Microbiol. Immunol. 204:125-143.[Medline]
49. Plasterk, R. H., and J. T. Groenen. 1992. Targeted alterations of the Caenorhabd